Compare AbCellera Biologics Inc (ABCL) vs American Tower Corp (AMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs American Tower Corp — how do they compare? AbCellera Biologics Inc trades at $9.03 (market cap $2.99B), while American Tower Corp trades at $169 (market cap $79.00B). The key difference: American Tower Corp is far larger — about 26.4× AbCellera Biologics Inc's market cap, and American Tower Corp pays a 4.12% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | AMT | |
|---|---|---|
Market Cap | $2.99B | $79.00B |
Sector | Health | Real Estate |
52-Week High | $9.76 | $211.88 |
52-Week Low | $2.78 | $162.11 |
Enterprise Value | $2.58B | $122.53B |
Dividend Yield | — | 4.12% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About American Tower Corp
American Tower owns and operates more than 220,000 cell towers throughout the U.S., Asia, Latin America, Europe, and Africa. It also owns and/or operates 25 data centers in eight U.S. markets after acquiring CoreSite. On its towers, the company has a very concentrated customer base, with most revenue in each market being generated by just the top few mobile carriers. The company operates more than 40,000 towers in the U.S., which accounted for more than half of its total revenue in 2021. Outside the U.S., American Tower's greatest presence is in India and Brazil, where it operates roughly 75,000 and 19,000 towers, respectively. American Tower operates as a real estate investment trust.
Read more on AMT →
